Project Grant 2126430
Award Date
12/1/21
Completion Date
11/30/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Awardee
Synvivia, Inc. (GBNJHAGHRVM6)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Albany, CA 94710, USA
Similar Awards
Zymosense Inc. received a $256,000 Project Grant award from the National Science Foundation Division of Industrial Innovation on December 1, 2021 to develop a platform for rapid assessment of hydrolytic enzyme activity to optimize their design and use. The award is being carried out under the Engineering program (CFDA 47.041) of the NSF Directorate for Engineering, which seeks to improve quality of life and economic strength through engineering research and innovation. Under this one-year...
Intrinsyx Bio Inc. was awarded a $254,735 Project Grant from the National Science Foundation on February 15, 2021 to complete work by September 30, 2022. The grant is part of the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to advance science and engineering research and innovation leading to breakthrough technologies as well as solutions to national challenges. Under this award, Intrinsyx Bio Inc. will conduct research at its location in Moffett Field, California to...
This $104,917 Project Grant award from the National Science Foundation's Biological Sciences (CFDA 47.074) program will support a team of undergraduate students at the University of Virginia in developing a low-cost treatment option for exocrine pancreatic insufficiency. The students will design and build a probiotic that secretes active synthetic pancreatic enzymes, gaining hands-on training in synthetic biology, molecular biology, and computational modeling. The project aims to introduce...
The National Science Foundation (NSF) awarded Pearl Bio, Inc., a biotechnology company, a $274,462 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funded the development of a next-generation biomanufacturing platform to engineer new microbial organisms and cellular machinery. This platform enables the incorporation of diverse, non-native components into proteins, creating a new class of biological materials for therapeutic development,...
This National Science Foundation (NSF) Project Grant award under the Biological Sciences program (CFDA 47.074) provides $429,656.00 to Cornell University to conduct research using synthetic biology methods to engineer microorganisms to produce valuable plant natural products. The key objectives are to reconstitute plant biosynthetic machinery in yeast in order to better understand and harness plant enzyme complexes for natural product synthesis. This research aims to develop a more resilient...
The National Science Foundation awarded Ancilia, Inc. a $255,717 Small Business Technology Transfer Phase I Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant will support development of phage-resistant bacterial therapeutics from July 2021 through June 2023. The NSF Technology, Innovation, and Partnerships program seeks to advance science, engineering, and technology innovation to address national challenges. Under this award, Ancilia...
The National Science Foundation (NSF) Directorate for Engineering awarded a $1,999,999 Project Grant under the CFDA 47.041 Engineering program to Virginia Polytechnic Institute & State University (Virginia Tech) on October 15, 2023. The objective of this 4-year project is to develop a biosensing platform that uses engineered living materials to continuously monitor for the presence of various airborne pathogens, including those that could be used as bioterrorism agents. The technology,...
This $228,697 National Science Foundation award under the Engineering program (CFDA 47.041) will support the development of an optical biosensor technology to facilitate drug screening and validation efforts. Auctus Biologics, Inc. will utilize a proprietary temperature, pH, and chemically stable protein composed of two fragments that bind with antibody-like affinity and specificity. Over the one-year period ending January 2023, the company will establish the technology's suitability for...
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
This Project Grant award from the National Science Foundation (NSF) under the Biological Sciences program (CFDA 47.074) provides $369,297 to San Francisco State University to develop a synthetic transhydrogenation module to enhance the production of valuable chemical compounds using engineered organisms. The key objectives are to: 1) understand and modify enzymes controlling cellular metabolism to enable more efficient production of high-value chemicals, 2) train undergraduate students in...